Expectedly, CD62L expression on CD8+ T cells in the blood of tumor-bearing mice was lower compared to non-tumor bearing mice; yet at later time-points, a similar level of expression of this marker was observed in both tumor and non-tumor bearing mice (Figure 4C). Here, SELL is linked to neoplasm.